Cargando…
Hospital urinary infection epidemic by Candida famata: reduction of mortality after therapy with fluconazole and identification of the risk factors related to the infection
Autores principales: | Lapchik, MS, Andrioli, E, Melo, M, Junior, P, Leiro, LC, Silva, EF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333012/ http://dx.doi.org/10.1186/cc808 |
Ejemplares similares
-
A case of central nervous system infection by Candida famata in an immunosuppressed patient with HIV-1 infection
por: Caria, Joao, et al.
Publicado: (2022) -
Preliminary characterization of the probiotic properties of Candida famata and Geobacillus thermoleovorans
por: Mahdhi, A, et al.
Publicado: (2011) -
Three Cases of Candidiasis Misidentified as Candida famata by the Vitek 2 System
por: Kim, Hyun-Young, et al.
Publicado: (2015) -
Cheese whey supports high riboflavin synthesis by the engineered strains of the flavinogenic yeast Candida famata
por: Ruchala, Justyna, et al.
Publicado: (2022) -
Fluconazole prophylaxis of systemic candida infection in non-neutropenic critically ill patients: a prospective randomized study
por: Parizkova, R, et al.
Publicado: (1999)